South African biotech firm Afrigen is seeking partners to help develop COVID-19 vaccines aimed at wealthy countries. This comes after international funders backed the mRNA project limits how much Afrigen can make from any mRNA vaccines sold in low- and middle-income countries. “We will need to produce a huge quantity of the vaccine,” the firm’s…